NatureWise Biotech & Medicals Dividends and Buybacks
Dividend criteria checks 0/6
NatureWise Biotech & Medicals is a dividend paying company with a current yield of 0.92%.
Key information
0.9%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | n/a |
| Dividend Growth | 14.6% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | NT$0.200 |
| Payout ratio | 63% |
Recent dividend and buyback updates
Recent updates
Lacklustre Performance Is Driving NatureWise Biotech & Medicals Corporation's (GTSM:4732) Low P/E
Apr 29
A Look At The Intrinsic Value Of NatureWise Biotech & Medicals Corporation (GTSM:4732)
Mar 25Here's Why We Don't Think NatureWise Biotech & Medicals's (GTSM:4732) Statutory Earnings Reflect Its Underlying Earnings Potential
Dec 20
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4732 is not paying a notable dividend for the TW market, therefore no need to check if payments are stable.
Growing Dividend: 4732 is not paying a notable dividend for the TW market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| NatureWise Biotech & Medicals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4732) | 0.9% |
| Market Bottom 25% (TW) | 1.8% |
| Market Top 25% (TW) | 4.5% |
| Industry Average (Personal Products) | 4.8% |
| Analyst forecast (4732) (up to 3 years) | n/a |
Notable Dividend: 4732's dividend (0.92%) isn’t notable compared to the bottom 25% of dividend payers in the TW market (1.78%).
High Dividend: 4732's dividend (0.92%) is low compared to the top 25% of dividend payers in the TW market (4.55%).
Earnings Payout to Shareholders
Earnings Coverage: 4732 is not paying a notable dividend for the TW market.
Cash Payout to Shareholders
Cash Flow Coverage: 4732 is not paying a notable dividend for the TW market.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 11:04 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
NatureWise Biotech & Medicals Corporation is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|